Sulwhasoo adds a ginseng-powered eye serum to its cult-favorite line
Sulwhasoo’s new $90 eye serum joins its First Care ritual with ginseng, peptides and a ceramic cooling tip, targeting puffiness, dark circles and firmness.

Sulwhasoo has added a matching eye serum to its First Care line, and the price lands at about $90 for 20mL, or 0.67 oz. It is designed as the latest step in the brand’s First Care ritual for the delicate eye area, with a promise to visibly firm, brighten and de-puff in one tidy daily treatment.
This is the right gift for the person who already loves a polished K-beauty routine and wants the set to feel complete. The formula leans on a 3-Peptide Blend, Ginseng Caffeine™ Complex and vitamin C derivatives, with a cooling ceramic tip and massager built in to make the application feel immediately soothing. That makes it an easy pick for anti-fatigue shoppers who are hunting for something that looks expensive, feels practical and does not read like another generic eye cream.
Sulwhasoo is also smartly leaning on the equity of the original First Care serum, now in its sixth generation. The brand calls First Care Activating Serum its No. 1 anti-aging serum in Korea and says one bottle sells every 10 seconds, based on 2019 to 2025 sell-in results. It adds that more than 520,000 customers have used more than 10 bottles each, using cumulative results from 1997 to 2025 in Korea. That kind of history matters for gifting because it turns the eye serum from a random launch into a matching extension of a cult routine people already trust.

At $90, this is not the kind of present I would give as a first step into Sulwhasoo. It makes more sense as an upgrade gift for someone who already has the First Care serum on the shelf, or for a luxe skincare giftee who cares about texture, ritual and visible payoff in the under-eye area. If the goal is to impress with one targeted product, this is stronger than buying a jumble of smaller eye-care items at the same spend. If the goal is to introduce someone to the brand, the original First Care serum still feels like the safer, more complete entry point.
This article was produced by Prism’s automated news system from verified source data, official records, and press releases, then run through automated quality and moderation checks before publishing. The system is built and supervised by the people who set the standards it runs under. Read our full AI policy.
Did this article answer your question?

